• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化石墨烯作为一种纳米载体,用于控制释放和靶向递送抗癌活性剂绿原酸。

Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.

机构信息

Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), Universiti Putra Malaysia UPM, 43400 Serdang, Selangor, Malaysia; Zabol University of Medical Sciences, Zabol, Iran.

Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), Universiti Putra Malaysia UPM, 43400 Serdang, Selangor, Malaysia.

出版信息

Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:177-185. doi: 10.1016/j.msec.2016.11.114. Epub 2016 Dec 5.

DOI:10.1016/j.msec.2016.11.114
PMID:28254283
Abstract

We have synthesized graphene oxide using improved Hummer's method in order to explore the potential use of the resulting graphene oxide as a nanocarrier for an active anticancer agent, chlorogenic acid (CA). The synthesized graphene oxide and chlorogenic acid-graphene oxide nanocomposite (CAGO) were characterized using Fourier transform infrared (FTIR) spectroscopy, thermogravimetry and differential thermogravimetry analysis, Raman spectroscopy, powder X-ray diffraction (PXRD), UV-vis spectroscopy and high resolution transmission electron microscopy (HRTEM) techniques. The successful conjugation of chlorogenic acid onto graphene oxide through hydrogen bonding and π-π interaction was confirmed by Raman spectroscopy, FTIR analysis and X-ray diffraction patterns. The loading of CA in the nanohybrid was estimated to be around 13.1% by UV-vis spectroscopy. The release profiles showed favourable, sustained and pH-dependent release of CA from CAGO nanocomposite and conformed well to the pseudo-second order kinetic model. Furthermore, the designed anticancer nanohybrid was thermally more stable than its counterpart. The in vitro cytotoxicity results revealed insignificant toxicity effect towards normal cell line, with a viability of >80% even at higher concentration of 50μg/mL. Contrarily, CAGO nanocomposite revealed enhanced toxic effect towards evaluated cancer cell lines (HepG2 human liver hepatocellular carcinoma cell line, A549 human lung adenocarcinoma epithelial cell line, and HeLa human cervical cancer cell line) compared to its free form.

摘要

我们使用改进的 Hummer 法合成了氧化石墨烯,以探索所得氧化石墨烯作为一种纳米载体用于活性抗癌剂绿原酸(CA)的潜在用途。使用傅里叶变换红外(FTIR)光谱、热重和差示热重分析、拉曼光谱、粉末 X 射线衍射(PXRD)、紫外可见光谱和高分辨率透射电子显微镜(HRTEM)技术对合成的氧化石墨烯和绿原酸-氧化石墨烯纳米复合材料(CAGO)进行了表征。通过拉曼光谱、FTIR 分析和 X 射线衍射图谱证实了绿原酸通过氢键和π-π相互作用成功接枝到氧化石墨烯上。通过紫外可见光谱估计 CA 在纳米杂化物中的负载量约为 13.1%。释放曲线表明,CAGO 纳米复合材料具有良好的、持续的和 pH 依赖性的 CA 释放,符合伪二级动力学模型。此外,设计的抗癌纳米杂化物比其对应物在热稳定性方面更优。体外细胞毒性结果表明,即使在较高浓度 50μg/mL 下,对正常细胞系也没有明显的毒性作用,细胞活力>80%。相比之下,CAGO 纳米复合材料对评估的癌细胞系(HepG2 人肝癌细胞系、A549 人肺腺癌细胞系和 HeLa 人宫颈癌细胞系)的毒性作用明显增强,与游离形式相比。

相似文献

1
Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.氧化石墨烯作为一种纳米载体,用于控制释放和靶向递送抗癌活性剂绿原酸。
Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:177-185. doi: 10.1016/j.msec.2016.11.114. Epub 2016 Dec 5.
2
Dual Drugs Anticancer Nanoformulation using Graphene Oxide-PEG as Nanocarrier for Protocatechuic Acid and Chlorogenic Acid.基于氧化石墨烯-聚乙二醇的双重药物抗癌纳米制剂用于原儿茶酸和绿原酸的载运
Pharm Res. 2019 Apr 24;36(6):91. doi: 10.1007/s11095-019-2621-8.
3
Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.透明质酸修饰的氧化石墨烯纳米杂化物作为靶向和 pH 响应型抗癌药物载体。
ACS Appl Mater Interfaces. 2014 Aug 13;6(15):11882-90. doi: 10.1021/am502423r. Epub 2014 Jul 16.
4
Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system.用于药物递送系统的壳聚糖包被磁性纳米颗粒对抗癌剂植酸的持续释放。
Int J Nanomedicine. 2017 Mar 27;12:2361-2372. doi: 10.2147/IJN.S126245. eCollection 2017.
5
Surface modification of graphene oxide with stimuli-responsive polymer brush containing β-cyclodextrin as a pendant group: Preparation, characterization, and evaluation as controlled drug delivery agent.将含β-环糊精侧基的刺激响应性聚合物刷接枝到氧化石墨烯表面:制备、表征及作为控释药物载体的评价。
Colloids Surf B Biointerfaces. 2018 Dec 1;172:17-25. doi: 10.1016/j.colsurfb.2018.08.017. Epub 2018 Aug 13.
6
Graphene Oxide Loaded with Protocatechuic Acid and Chlorogenic Acid Dual Drug Nanodelivery System for Human Hepatocellular Carcinoma Therapeutic Application.载原儿茶酸和绿原酸的氧化石墨烯双重药物纳米递药系统用于人肝癌的治疗应用。
Int J Mol Sci. 2021 May 28;22(11):5786. doi: 10.3390/ijms22115786.
7
Graphene Oxide as a Nanocarrier for a Theranostics Delivery System of Protocatechuic Acid and Gadolinium/Gold Nanoparticles.氧化石墨烯作为原儿茶酸和钆/金纳米粒子治疗学递药系统的纳米载体。
Molecules. 2018 Feb 24;23(2):500. doi: 10.3390/molecules23020500.
8
Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.生物素分子靶向载阿霉素κ-卡拉胶接枝氧化石墨烯纳米载体的癌细胞给药系统的构建。
Mater Sci Eng C Mater Biol Appl. 2019 Jul;100:676-687. doi: 10.1016/j.msec.2019.03.011. Epub 2019 Mar 4.
9
Synthesis and characterization of Zinc (II)-loaded Zeolite/Graphene oxide nanocomposite as a new drug carrier.负载锌(II)的沸石/氧化石墨烯纳米复合材料作为新型药物载体的合成与表征
Mater Sci Eng C Mater Biol Appl. 2016 Sep 1;66:251-258. doi: 10.1016/j.msec.2016.04.090. Epub 2016 Apr 26.
10
Physiochemical and optical properties of chitosan based graphene oxide bionanocomposite.基于壳聚糖的氧化石墨烯生物纳米复合材料的物理化学和光学性质
Int J Biol Macromol. 2014 Sep;70:559-64. doi: 10.1016/j.ijbiomac.2014.07.019. Epub 2014 Jul 28.

引用本文的文献

1
Synthesis and Characterization of Graphene Oxide/Polyethylene Glycol/Folic Acid/Brucine Nanocomposites and Their Anticancer Activity on HepG2 Cells.石墨烯氧化物/聚乙二醇/叶酸/马钱子堿纳米复合材料的合成与表征及其对 HepG2 细胞的抗癌活性。
Int J Nanomedicine. 2024 Feb 5;19:1109-1124. doi: 10.2147/IJN.S445206. eCollection 2024.
2
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis.关于绿原酸在疾病治疗中的治疗功效、临床试验和新型给药系统的最新进展,特别强调溃疡性结肠炎。
Curr Pharm Des. 2024;30(6):420-439. doi: 10.2174/0113816128295753240129074035.
3
Antioxidant potential of chlorogenic acid in Age-Related eye diseases.
绿原酸在年龄相关性眼病中的抗氧化潜力。
Pharmacol Res Perspect. 2024 Feb;12(1):e1162. doi: 10.1002/prp2.1162.
4
Preparation of graphene oxide-stabilized Pickering emulsion adjuvant for Pgp3 recombinant vaccine and enhanced immunoprotection against infection.制备氧化石墨烯稳定的 Pickering 乳液佐剂用于 Pgp3 重组疫苗,并增强对 感染的免疫保护。
Front Immunol. 2023 Apr 18;14:1148253. doi: 10.3389/fimmu.2023.1148253. eCollection 2023.
5
Rapid and efficient testing of the toxicity of graphene-related materials in primary human lung cells.快速高效地检测人原代肺细胞中与石墨烯相关的材料的毒性。
Sci Rep. 2022 May 10;12(1):7664. doi: 10.1038/s41598-022-11840-2.
6
The Genus : Phytochemical and Ethnopharmacological Perspectives.该属:植物化学与民族药理学视角。
Front Pharmacol. 2022 Apr 11;13:769111. doi: 10.3389/fphar.2022.769111. eCollection 2022.
7
Graphene Oxide Thin Films with Drug Delivery Function.具有药物递送功能的氧化石墨烯薄膜
Nanomaterials (Basel). 2022 Mar 30;12(7):1149. doi: 10.3390/nano12071149.
8
Graphene and graphene oxide with anticancer applications: Challenges and future perspectives.具有抗癌应用的石墨烯及氧化石墨烯:挑战与未来展望。
MedComm (2020). 2022 Feb 9;3(1):e118. doi: 10.1002/mco2.118. eCollection 2022 Mar.
9
Cell viability and electrical response of breast cancer cell treated in aqueous graphene oxide solution deposition on interdigitated electrode.水相氧化石墨烯溶液沉积于叉指电极上处理的乳腺癌细胞的细胞活力和电响应。
Sci Rep. 2021 Oct 19;11(1):20702. doi: 10.1038/s41598-021-00171-3.
10
Controlled Release of Chlorogenic Acid from Polyvinyl Alcohol/Poly(γ-Glutamic Acid) Blended Electrospun Nanofiber Mats with Potential Applications in Diabetic Foot Treatment.从聚乙烯醇/聚(γ-谷氨酸)共混电纺纳米纤维垫中可控释放绿原酸及其在糖尿病足治疗中的潜在应用
Polymers (Basel). 2021 Aug 31;13(17):2943. doi: 10.3390/polym13172943.